Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emerg...
November 27 2017 - 6:27PM
Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for
#GivingTuesday, November 28th, a global day of giving that
harnesses the collective power of individuals, communities and
organizations to encourage philanthropy and to celebrate generosity
worldwide.
Accelerate Diagnostics has pledged to match the first $10,000
gifted to Sepsis Alliance on #GivingTuesday to help raise awareness
of sepsis as an often preventable medical emergency.
Sepsis is the body's life-threatening response to infection
that can affect anyone and lead to death. According to the Sepsis
Alliance, the leading U.S. organization dedicated to this cause, as
many as forty percent of patients diagnosed with septic shock do
not survive. Early recognition and appropriate antibiotics are keys
to treating sepsis.
“We’re glad to support this important worldwide effort to
raise awareness of this life-threatening emergency that is so often
misunderstood,” said Larry Mehren, President & CEO of
Accelerate Diagnostics. “The commitment from the team at Sepsis
Alliance to create meaningful improvements for patients is evident
and aligns well with our own to make life-saving decisions easier
for clinicians and safer for patients afflicted with serious
infections.”
To donate to the Sepsis Alliance campaign, please
visit: https://donate.sepsis.org/checkout/donation?eid=155997
About Sepsis Alliance
Sepsis Alliance is the nation’s leading sepsis advocacy
organization, dedicated to saving lives by raising awareness of
sepsis as a medical emergency. A 501(c)(3) organization, Sepsis
Alliance was founded by Dr. Carl Flatley after the sudden,
unnecessary death of his daughter Erin to a disease he had never
even heard of. Sepsis Alliance produces and distributes educational
materials for patients, families and health providers on sepsis
prevention, early recognition and treatment. The organization also
offers support to patients, sepsis survivors, and family members
through its sepsis.org website which receives more than 1.5 million
visits each year. The organization founded Sepsis Awareness Month
in 2011, and works with partners to host community outreach events
across North America. Since Sepsis Alliance began its mission,
sepsis awareness has increased threefold, from 19% to 58%. For more
information on Sepsis Alliance, a GuideStar Gold-rated charity,
please visit http://www.sepsis.org/.
About #GivingTuesday
#GivingTuesday is a global giving movement that has been built
by individuals, families, organizations, businesses and communities
in all 50 states and in countries around the world. This year,
#GivingTuesday falls on November 28. #GivingTuesday harnesses the
collective power of a unique blend of partners to transform how
people think about, talk about, and participate in the giving
season. It inspires people to take collective action to improve
their communities, give back in better, smarter ways to the
charities and causes they believe in, and help create a better
world. Every act of generosity counts, and they mean even more when
we give together. To learn more about #GivingTuesday, please visit:
www.givingtuesday.org.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. (“Accelerate”) (Nasdaq:AXDX), is an
in vitro diagnostics company dedicated to providing solutions for
the global challenge of antibiotic resistance and
healthcare-associated infections. The company recently obtained FDA
marketing authorization for antimicrobial susceptibility testing
direct from positive blood culture samples using its Accelerate
Pheno™ system and Accelerate PhenoTest™ BC kit. The system and kit
leverage proprietary molecular identification methods and
morphokinetic cellular analysis (MCA) to provide minimum inhibitory
concentrations for a range of applicable antibiotics. The
fully-automated system is designed to eliminate the lengthy culture
and sample preparation steps required prior to antimicrobial
susceptibility testing. Recent market studies suggest the solution
offers results 1-2 days faster than conventional methods, enabling
clinicians to optimize antibiotic selection, dosage, and infusion
strategy specific to the individual patient and their infection. To
learn more, visit axdx.com. The “ACCELERATE DIAGNOSTICS” and
“ACCELERATE PHENO” and “ACCELERATE PHENOTEST” and diamond-shaped
logos and marks are trademarks or registered trademarks of
Accelerate Diagnostics, Inc.
Media Contact:Andrew Chasteen+1 520 365-3100
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Apr 2023 to Apr 2024